日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling.

SIRT2 介导的 LCK 去乙酰化控制着 T 细胞受体信号的强度。

Hamaidi Imene, Cheng Pingyan, Jun Soo Young, Manna Alak, Wang Min-Hsuan, Nguyen Anh, Can Ismail, Zhang Min G, Taylor Odesha O, Bailon Luis Uriel Lopez, Fang Bin, Perez Bradford, Creelan Ben C, Marusyk Andriy, Shin Dongjun, Hwang Tae Hyun, Berglund Anders E, Shapiro Virginia S, Ji Haitao M, Conejo-Garcia José R, Kim Sungjune

RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wild-Type RAS Activation in Non-Small Cell Lung Cancer

RAS-GTP抑制剂可克服非小细胞肺癌中由致癌性和野生型RAS激活介导的对KRASG12C抑制剂的获得性耐药性

Solanki, Hitendra S; Shah, Harshit; Imbody, Denis; Desai, Bina; Kato, Ryoji; Miroshnychenko, Daria; Stern, Yaakov E; Majumder, Anurima; Sarcar, Bhaswati; Xieraili, Aobuli; Stewart, Paul A; Fang, Bin; Zhang, Yonghong; Yao, Jiqiang; Darville, Lancia N; Koomen, John M; Rix, Uwe; Evans, James W; Yang, Yu Chi; Ahler, Ethan; Marusyk, Andriy; Singh, Mallika; Aronchik, Ida; Haura, Eric B

In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer.

原位 RAS:RAF 结合与 KRASG12C 突变型非小细胞肺癌对 KRASG12C 抑制剂的反应相关

Kato Ryoji, Solanki Hitendra S, Ozakinci Hilal, Desai Bina, Gundlapalli Harika, Yang Yu Chi, Aronchik Ida, Singh Mallika, Johnson Joseph, Marusyk Andriy, Boyle Theresa A, Haura Eric B

The adaptive state determines the impact of mutations on evolving populations

适应状态决定了突变对不断进化的种群的影响。

Tyczynska Weh, Malgorzata; Kumar, Pragya; Marusyk, Viktoriya; Marusyk, Andriy; Basanta, David

Cancer-associated fibroblasts confer ALK inhibitor resistance in EML4-ALK-driven lung cancer by concurrent integrin and MET signaling.

癌症相关成纤维细胞通过同时激活整合素和MET信号通路,使EML4-ALK驱动的肺癌对ALK抑制剂产生耐药性。

Hu Qianqian, Remsing Rix Lily L, Desai Bina, Miroshnychenko Daria, Li Xueli, Welsh Eric A, Fang Bin, Wright Gabriela M, Chaudhary Neelkamal, Kroeger Jodi L, Doebele Robert C, Koomen John M, Haura Eric B, Marusyk Andriy, Rix Uwe

The role of environmentally mediated drug resistance in facilitating the spatial distribution of residual disease

环境介导的耐药性在促进残留疾病的空间分布中的作用

Milne, Amy; Marusyk, Andriy; Maini, Philip K; Anderson, Alexander R A; Picco, Noemi

Leveraging selection for function in tumor evolution: System-level cancer therapies

利用选择机制促进肿瘤进化中的功能:系统级癌症疗法

Thomas, Frédéric; Capp, Jean-Pascal; Dujon, Antoine M; Marusyk, Andriy; Asselin, Klara; Campone, Mario; Pujol, Pascal; Alix-Panabières, Catherine; Roche, Benjamin; Ujvari, Beata; Gatenby, Robert; Nedelcu, Aurora M

Evolutionary antifragile therapy

进化反脆弱疗法

West, Jeffrey; Desai, Bina; Strobl, Maximilian; Gallaher, Jill; Robertson-Tessi, Mark; Marusyk, Andriy; Anderson, Alexander R A

Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancers.

多因素基质介导的耐药性是肺癌靶向治疗后残留病灶的主要原因

Desai Bina, Miti Tatiana, Prabhakaran Sandhya, Miroshnychenko Daria, Henry Menkara, Marusyk Viktoriya, Kumar Pragya, Ozakinci Hilal, Gatenbee Chandler, Bui Marilyn, Boyle Theresa A, Scott Jacob, Altrock Philipp M, Haura Eric, Anderson Alexander R A, Basanta David, Marusyk Andriy

Cellular adaptation to cancer therapy along a resistance continuum.

细胞对癌症治疗的适应性沿着耐药性连续谱发展

França Gustavo S, Baron Maayan, King Benjamin R, Bossowski Jozef P, Bjornberg Alicia, Pour Maayan, Rao Anjali, Patel Ayushi S, Misirlioglu Selim, Barkley Dalia, Tang Kwan Ho, Dolgalev Igor, Liberman Deborah A, Avital Gal, Kuperwaser Felicia, Chiodin Marta, Levine Douglas A, Papagiannakopoulos Thales, Marusyk Andriy, Lionnet Timothée, Yanai Itai